Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 9.65B | 7.88B | 7.13B | 6.72B | 5.75B | 5.29B |
Gross Profit | 4.42B | 3.66B | 3.29B | 3.17B | 2.58B | 2.33B |
EBITDA | 2.02B | 1.91B | 1.64B | 1.60B | 1.31B | 1.22B |
Net Income | 1.44B | 1.18B | 1.13B | 1.08B | 820.23M | 729.66M |
Balance Sheet | ||||||
Total Assets | 11.33B | 12.06B | 10.73B | 9.87B | 8.38B | 7.49B |
Cash, Cash Equivalents and Short-Term Investments | 2.84B | 3.36B | 1.57B | 2.25B | 2.03B | 1.21B |
Total Debt | 0.00 | 35.30M | 60.99M | 72.55M | 8.95M | 8.42M |
Total Liabilities | 1.35B | 1.49B | 1.35B | 1.54B | 1.09B | 964.71M |
Stockholders Equity | 9.81B | 10.38B | 9.25B | 8.22B | 7.21B | 6.47B |
Cash Flow | ||||||
Free Cash Flow | 82.44M | 0.00 | -325.74M | 360.03M | 945.07M | 935.31M |
Operating Cash Flow | 82.44M | 2.06B | 376.96M | 620.26M | 1.26B | 981.10M |
Investing Cash Flow | 0.00 | -87.46M | -845.83M | -259.76M | -317.45M | -9.77M |
Financing Cash Flow | 0.00 | 0.00 | -244.45M | -173.02M | -154.54M | -243.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $448.73B | 13.77 | 18.84% | 1.83% | 22.07% | 39.05% | |
74 Outperform | ¥878.70B | 14.70 | 8.10% | 2.30% | 8.60% | 10.83% | |
71 Outperform | ¥313.13B | 29.13 | 4.03% | 3.06% | 2.87% | 2.48% | |
71 Outperform | ¥254.55B | 13.00 | 8.49% | 3.09% | 6.31% | 12.77% | |
68 Neutral | ¥320.06B | 31.83 | 4.90% | 0.99% | 24.85% | ||
67 Neutral | ¥9.45B | 8.02 | 2.84% | 10.57% | 4.16% | ||
65 Neutral | ¥38.74B | 38.53 | 3.48% | -1.21% | -62.52% |